Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-08-18

Delgado-Calle Jesus

Researcher

Also affiliated: Winthrop Rockefeller Foundation (2026); Indiana University School of Medicine (2019); Indiana University – Purdue University Indianapolis (2019)

Graduate Student Researcher

2 pubs

  • Receptor, Notch3
  • Multiple Myeloma
  • Drug Resistance, Neoplasm
  • Animals
  • Antineoplastic Agents
  • Disease Models, Animal
  • Humans
  • Signal Transduction
  • Xenograft Model Antitumor Assays
  • Cell Line, Tumor
  • Mice

Biography and Research Information

OverviewAI-generated summary

Research by Jesus Delgado-Calle focuses on the molecular mechanisms of multiple myeloma, particularly targeting the Notch3 receptor to overcome therapy resistance and eliminate dormant cancer cells. His work has contributed to understanding how Notch3 signaling influences the survival and persistence of multiple myeloma cells, even after treatment. This research involves the use of various cellular and animal models to investigate potential therapeutic strategies. Delgado-Calle collaborates with researchers at the University of Arkansas for Medical Sciences, including Japneet Kaur, Elena Ambrogini, C. Lowry Barnes, and Jeffrey B. Stambough, with whom he has co-authored publications.

Metrics

  • Publications: 2

Selected Publications

  • Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
    Journal of Experimental & Clinical Cancer Research DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

16 Collaborators 7 Institutions 2 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics